New Ipsos global survey shines a light on the myopia epidemic

Myopia, or short-sightedness, is predicted to impact half of the World's population and a staggering one billion people are predicted to have high myopia by 2050^[2].

Higher degrees of myopia pose a greater risk of ocular complications that may lead to visual impairment or even blindness later in life. However, the earlier myopia is detected and managed in a child, the greater the chance progression can be slowed down with simple lifestyle changes and by wearing special myopia control glasses or contact lenses available from your local optician.

The poll highlighted huge gaps in knowledge amongst parents around myopia:

Charlotte Timbury, Dispensing Optician and Director of Medical & Professional Affairs for EssilorLuxottica North Europe said: "Myopia, or short-sightedness, is when a child can see close up objects but struggles to see objects far away clearly, such as the whiteboard at school. This typically develops in children of school age and the younger a child becomes myopic, the more likely they will develop higher levels of myopia^[3].

"It's evident that many parents and even those whose children are myopic, lack accurate information about myopia. Worryingly, many think that simply making their child wear glasses with corrective lenses solves the problem, unaware that myopia can progress even with corrective lenses.

"However, there are ways to slow it down with lifestyle changes and wearing a myopia control spectacle lens, such as Essilor Stellest lenses, which will correct myopia and slow down its progression."

More than correction: There is an urgency for long-term myopia management

The survey reveals that the majority of parents take a short-term view of myopia management, focusing on immediate compensation for the problem, overlooking the importance of follow-ups once the correction is in place and the existence of solutions to slow down the progression.

Charlotte continues: "Myopia must be addressed and managed as soon as possible in childhood, and thankfully, recent developments in myopia control spectacle lenses can help this. Essilor Stellest lenses are safe and easy to wear and enable the child to continue to wear their spectacles without any compromise. In fact, over a 5-year period, myopia progression was two times slower on average with Essilor Stellest lenses*^[4].

"This, combined with some simple lifestyle changes can help reduce the risk of high myopia and its potentially associated complications once the child reaches adulthood.

"Getting outside as much as possible and keeping leisure screen time outside of schoolwork to a minimum has been shown to help delay the onset of myopia. Myopia can progress rapidly so it's important to know the signs to watch out for such as sitting too close to the TV and difficulty seeing the board at school, and for children to keep up with their regular eye examination once a year."

About Essilor® Stellest®

Essilor® Stellest® lenses are Essilor®'s best solution for fighting myopia in children because they have two functions. First, they correct myopia, giving the wearer sharp vision. And second, they slow down its progression by positioning a volume of non-focused light in front of the retina, following the retina's shape which sends a signal to slow down eye elongation.

Essilor® Stellest® lenses slow down the progression of myopia by 67% on average, compared to single vision lenses, when worn 12 hours per day**^[5].

Visit https://www.essilor.com/uk-en/products/stellest/.

About Essilor®: 

Essilor®, part of EssilorLuxottica's portfolio, is a leader in eyeglass lenses worldwide^[6] and the number one lens brand recommended by eye care professionals (ECP)^[7]. It offers a complete range of solutions dedicated to each individual's vision and lifestyle needs throughout their life. Every Essilor® lens is a combination of multiple complementary technologies thanks to its suite of leading premium vision care solutions, including innovative brands such as Stellest®, Eyezen® and Varilux® and Crizal®. These groundbreaking technologies correct vision, protect eyes from UV rays and enhance visual clarity. 

REFERENCES:

^1. International survey conducted by Ipsos in 6 countries on 6007 parents with at least one child aged from 5 to 17, from a representative sample of individuals aged from 25 to 60 in terms of age, gender, occupation, region. UK: 1000 interviews / Italy: 1001 interviews / France: 1000 interviews / Brazil: 1001 interviews / India: 1005 interviews / China: 1000 interviews. Online interviews from June 24th to July 15th 2024.
^2. Source: Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006.
^3. Bullimore MA, Richdale K. Myopia Control 2020: Where are we and where are we heading? Ophthal Physiol Opt 2020;40:254–270.
^4. Li X, Huang Y, Liu C, Yin Z, Cui Z, Lim EW, Drobe B, Chen H, Bao J. Myopia control efficacy of spectacle lenses with highly aspherical lenslets: results of a 5-year follow-up study. Presented at the Association for Research in Vision and Ophthalmology (ARVO)Annual Meeting, Seattle, 2024.
^5. Bao, J., Huang, Y., Li, X., Yang, A., Zhou, F., Wu, J., Wang, C., Li, Y., Lim, E.W., Spiegel, D.P., Drobe, B. and Chen, H., 2022. "Spectacle Lenses with Aspherical Lenslets for Myopia Control vs Single Vision Spectacle Lenses: A Randomized Clinical Trial." JAMA Ophthalmol. 1 40(5), 472 – 478. https://doi.org/10.1001/jamaophthalmol.2022.0401.
^6. Source: Euromonitor, Eyewear 2023 edition; Essilor International company; worldwide retail value sales at RSP.
^7. Quantitative research conducted among a representative sample of 958 independent ECPs by CSA in February 2019 – France, the UK, Germany, Italy, Spain, the US, Canada, Brazil, China, India. 

DISCLAIMERS:

*Compared to the 60-month progression of the extrapolated control group (predicted average annual decrease in SER by 9.7% based on the initial 2-year control group, Smotherman C, et al. IOVS 2023;64:ARVO E-Abstract 811).
**Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Essilor® Stellest® lenses compared to 50 myopic children wearing single vision lenses in Wenzhou China. Results based on 32 children from the Test Group wearing Essilor® Stellest® lenses at least 12 hours per day every day for two consecutive years.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/new-ipsos-global-survey-shines-a-light-on-the-myopia-epidemic-302302559.html